These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet? Christianson S; Grierson W; Wolfe J; Sharma MK J Clin Microbiol; 2013 Jul; 51(7):2425-6. PubMed ID: 23658257 [TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China. Zhao X; Wang Y; Pang Y Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease. Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413 [TBL] [Abstract][Full Text] [Related]
20. Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice. Bermudez LE; Nash K; Petrofsky M; Young LS; Inderlied CB Antimicrob Agents Chemother; 2000 Oct; 44(10):2619-22. PubMed ID: 10991834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]